ArticleMicrochemical journal : devoted to the application of microtechniques in all branches of science2026
Overcoming Peptide Instability in Blood: Development and Validation of a Stabilized LC-MS/MS Method for a 15-mer Peptide B4-007 in Pharmacokinetic Studies.
Article in Microchemical journal : devoted to the application of microtechniques in all branches of science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Simultaneous detection of multiple foodborne pathogens using a CRISPR/Cas12a-based pump-free microfluidic chip.Analytical and bioanalytical chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Background: Peptide therapeutics pose significant analytical challenges in pharmacokinetic studies due to rapid degradation in biological matrices, particularly whole blood, where proteolytic activity can lead to substantial ex vivo loss. These challenges are amplified in small-animal studies that rely on microliter-scale sampling, where plasma separation is impractical, and whole blood must be directly analyzed. Despite existing stabilization strategies, their effectiveness in whole blood remains insufficiently understood. Results: In this study, we performed a systematic evaluation of multiple stabilization approaches for the 15-mer peptide B4-007 in mouse whole blood and identified limitations of commonly used methods, including incomplete protection by protease inhibitors and instability following organic solvent treatment without matrix removal. Based on these findings, we developed an integrated stabilization workflow involving immediate acidification with a relatively high concentration of formic acid (10%), followed by acetonitrile-mediated protein precipitation and matrix cleanup. This combined strategy effectively suppressed enzymatic degradation and preserved peptide integrity. The optimized workflow was coupled with LC-MS/MS analysis and validated over a range of 1-1000 ng/mL using only 5 μL of whole blood, meeting the U.S. Food and Drug Administration bioanalytical validation criteria. The method was successfully applied to a preliminary pharmacokinetic study in mice. Significance: This work provides a systematic assessment of peptide stabilization strategies in whole blood and demonstrates that combining rapid acidification with organic solvent quenching and matrix removal can overcome limitations of existing approaches. The study offers practical methodological insights and a robust workflow as a starting point for developing stabilization strategies for other labile peptides in low-volume whole blood samples.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.